China Pharmaceuticals and Healthcare Report Q1 2015
PR Newswire - Wed Dec 24, 7:30AM CST
BMI View:Improvements in intellectual property protection, an ageing population and increasing access to healthcare will drive the robust growth of China's pharmaceutical market. This will attract foreign drug manufacturers despite the downside risks of pharmaeconomics and the government's crackdown on illegal practices.